Search Results - David Hurd

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype by Wyndham H. Wilson, Sin-Ho Jung, Pierluigi Porcu, David Hurd, Jeffrey Johnson, S. Eric Martin, Myron Czuczman, Raymond Lai, Jonathan Said, Amy Chadburn, Dan Jones, Kieron Dunleavy, George Canellos, Andrew D. Zelenetz, Bruce D. Cheson, Eric D. Hsi

    Published in Haematologica (2012-05-01)
    Get full text
    Article


  2. 2

    P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA by Katja Weisel, Anita D’souza, David Hurd, Peter Voorhees, Raphael Teipel, Alfred Chung, Cesar Rodriguez, Sacha Tuchman, Neha Korde, Hana Safah, Orlando Bueno, Zhongling Feng, Tanya Rosenberg, Rajvineeth Kumar Pothacamury, Jeremy Ross, Shane Lee, Ziyi Jin, Chetasi Talati, Shaji Kumar, Ravi Vij

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


Search Tools: